Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review

Monoclonal antibodies (mAb) are promising therapeutics in multiple sclerosis and multiple new candidates have been developed, hence increasing the need for some agreement for preclinical mAb studies. We systematically analyzed publications of experimental autoimmune encephalomyelitis (EAE) studies s...

Full description

Bibliographic Details
Main Authors: Katja Schmitz, Gerd Geisslinger, Irmgard Tegeder
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/18/9/1992